(Q46533193)

22 December 2017

title

The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism (English)

1 reference

22 December 2017

0 references

1 reference

Ute Eisenberger

2

0 references

author name string

Anja E Kruse

series ordinal

1

1 reference

22 December 2017

Felix J Frey

series ordinal

3

1 reference

22 December 2017

Markus G Mohaupt

series ordinal

4

1 reference

22 December 2017

language of work or name

English

0 references

publication date

7 June 2005

1 reference

22 December 2017

Nephrology Dialysis Transplantation

published in

1 reference

22 December 2017

volume

20

1 reference

22 December 2017

issue

7

1 reference

22 December 2017

page(s)

1311-1314

1 reference

22 December 2017

Involution of the parathyroid glands after renal transplantation

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH924

Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH924

Evolution of secondary hyperparathyroidism after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH924

Modulation and action of the calcium-sensing receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH924

Calcimimetics with potent and selective activity on the parathyroid calcium receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH924

Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH924

The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH924

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH924

Treatment of secondary hyperparathyroidism of dialysis patients with calcimimetics as a valuable addition to established therapeutic means

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH924

Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH924

The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH924

Molecular mechanisms in proximal tubular and small intestinal phosphate reabsorption (plenary lecture).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH924

Effects of parathyroidectomy on renal allograft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH924

21 January 2018

Identifiers

DOI

10.1093/NDT/GFH924

1 reference

22 December 2017

PubMed ID

15941846

1 reference

22 December 2017